# Phase 22 Independent Validation Review

## Scope

Validated Phase 22 conformance and integration sealing across the compiler, JVM emitter/artifact boundary, runtime loader/lifecycle, standard I/O, CLI, class-directory/thin/bundled packaging, generated Java facades, source maps, compatibility preflight, and deterministic publication. Later performance and release phases were not started.

## Findings

- The Phase 22 matrix now covers complete source-to-IR/bytecode execution, malformed and deferred syntax diagnostics, module order/cycles, independent instances, exact handles, runtime failures, owner-thread and close behavior, raw-array escape, corruption/profile rejection, external `-Xverify:all`, class/thin/bundled artifacts, Java consumer compilation, metadata/debug-map integrity, and CLI subprocess behavior.
- Repeated compilation of the same source snapshot and options is byte-identical for metadata, generated class bytes, and all artifact entries.
- Intrinsic `std->io` closure adapters are generated classes without lambda origins. `JvmBytecodeArtifact.emittedMethods()` now resolves their declaration origin from `GeneratedTypePlan.intrinsicFunctionClasses()` rather than treating the adapter as an ordinary lambda. This allows debug-map construction and artifact assembly for intrinsic imports while retaining source-mapped intrinsic frames.
- No remaining Phase 22 defect was found after the repair and focused/broad validation.

## Risk Assessment

Low for the exercised Java 25/Linux path. Maven emits existing `ThreadDeath` deprecation and shade manifest-overlap warnings only. Native Windows script execution and numerical performance evidence remain outside this Phase 22 validation result and belong to their specified later gates.

## Recommendations

Keep intrinsic adapter origins explicit in the emission metadata path; intrinsic closures are not parser/semantic lambdas and must not be forced through lambda-only source-origin lookup. Keep clean Maven validation serial when commands share module `target` directories.

## Follow-ups

Phase 23 owns JMH/allocation evidence and threshold ratification. Phase 24 owns the final requirement matrix and release review.
